023910 — Dai Han Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Annual balance sheet for Dai Han Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	96,415	97,607	104,359	77,237	89,535
Net Total Accounts Receivable
Net Total Receivables	30,384	33,264	31,878	33,309	34,906
Total Inventory
Prepaid Expenses
Total Current Assets	147,539	155,886	159,905	137,366	158,492
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	113,831	113,236	125,853	134,441	153,399
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	272,542	276,980	294,252	324,411	347,663
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46,119	42,686	41,300	42,644	43,508
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	69,734	51,582	46,278	48,418	47,450
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	202,808	225,398	247,974	275,994	300,214
Total Liabilities & Shareholders' Equity	272,542	276,980	294,252	324,411	347,663
Total Common Shares Outstanding